EUVIMEDEUVIMED entdecken
Open Access

Precision medicine approach to coronary artery disease: Haptoglobin phenotype‑guided risk assessment

Zhengxin He, Hong Liu, Keran Jia, Daxin Lei, Liyun An, Jia Wang, Fukun Wang

Molecular Medicine Reports · 12.03.2026 · 33 (5) · 1-9

DOI: 10.3892/mmr.2026.13844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Medicine Reports, online erschienen am 12.03.2026. Verfasst von Zhengxin He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Basic Medicine, Bethune International Peace Hospital, Shijiazhuang, Hebei 050082, P.R. China. Hauptthemen laut MEDLINE: Haptoglobins, Coronary Artery Disease, Precision Medicine. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HaptoglobinsCoronary Artery DiseasePrecision MedicineHumansFemaleMaleMiddle AgedPhenotypeGenotypeRisk AssessmentAgedGenetic Predisposition to DiseaseRisk FactorsCase-Control StudiesBiomarkersPolymorphism, Genetic

Stichwörter der Autor:innen

Chinese populationcoronary artery diseasehaptoglobinpolymorphism

Substanzen

HaptoglobinsBiomarkersHP protein, human

Autor:innen und Institutionen

  • Laboratory of Basic Medicine, Bethune International Peace Hospital, Shijiazhuang, Hebei 050082, P.R. China.
  • Department of Ultrasonography, Bethune International Peace Hospital, Shijiazhuang, Hebei 050082, P.R. China.
  • Department of Laboratory Medicine, Bethune International Peace Hospital, Shijiazhuang, Hebei 050082, P.R. China.

Zitieren

APA

He, Z., Liu, H., Jia, K., Lei, D., An, L., Wang, J., & Wang, F. (2026). Precision medicine approach to coronary artery disease: Haptoglobin phenotype‑guided risk assessment. Molecular Medicine Reports, 33(5), 1-9. https://doi.org/10.3892/mmr.2026.13844

Vancouver

He Z, Liu H, Jia K, Lei D, An L, Wang J, et al. Precision medicine approach to coronary artery disease: Haptoglobin phenotype‑guided risk assessment. Molecular Medicine Reports. 2026;33(5):1-9. doi:10.3892/mmr.2026.13844

BibTeX
@article{He2026,
  author = {He, Zhengxin and Liu, Hong and Jia, Keran and Lei, Daxin and An, Liyun and Wang, Jia and Wang, Fukun},
  title = {Precision medicine approach to coronary artery disease: Haptoglobin phenotype‑guided risk assessment},
  journal = {Molecular Medicine Reports},
  year = {2026},
  volume = {33},
  number = {5},
  pages = {1--9},
  doi = {10.3892/mmr.2026.13844}
}
Kostenlos starten →